No, I don't think you were wrong. I personally see this as an opportunity to set out a pathway to the future and all I saw was the dog ate my homework.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
